Page last updated: 2024-11-04
risedronic acid and Neoplasms, Pleural
risedronic acid has been researched along with Neoplasms, Pleural in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Dell'Anno, I | 1 |
Martin, SA | 1 |
Barbarino, M | 1 |
Melani, A | 1 |
Silvestri, R | 1 |
Bottaro, M | 1 |
Paolicchi, E | 1 |
Corrado, A | 1 |
Cipollini, M | 1 |
Melaiu, O | 1 |
Giordano, A | 1 |
Luzzi, L | 1 |
Gemignani, F | 1 |
Landi, S | 1 |
Other Studies
1 other study available for risedronic acid and Neoplasms, Pleural
Article | Year |
---|---|
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma.
Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Drug Repositioning; Gene Expres | 2021 |